Evaluation of the Videodrama Therapeutic Device for Children With Autism Spectrum Disorders
Centre Hospitalier Intercommunal Robert Ballanger
30 participants
Dec 4, 2023
INTERVENTIONAL
Conditions
Summary
Autism spectrum disorder (ASD) is a neurodevelopmental disorder (Valerie, Sperenza, 2009) that begins early in development, characterized by persistent deficits in communication and social interactions across various contexts and restricted, repetitive patterns of behavior, interests, or activities. These symptoms significantly impact social, school/professional functioning, or other important areas and are not better explained by intellectual disability or global developmental delay (American Psychiatric Association, 2013).
Eligibility
Inclusion Criteria8
- Children aged 3 to 15 years.
- Clinically confirmed ASD by a psychiatrist.
- Parental or legal guardian consent for participation.
- Child showing a strong interest in screens and/or video content.
- Ability to tolerate the presence of other children.
- Minimum of 18 video drama sessions.
- Not having benefited from disease care in the past.
- Affiliation to a social security system
Exclusion Criteria6
- No ASD diagnosis.
- Younger than 3 or older than 15 at the study start.
- No interest in screens or video content.
- Parental or legal guardian refusal for participation.
- Dropping out before completing 18 sessions.
- Patient having benefited a disease care in the past
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients included in the videodrama arm will participate in a total of 18 videodrama sessions, with one session per week. Each session will include a patient welcome period, the viewing of a video excerpt (in slow motion or not), a playtime, a drawing period, and a group closing session. For the play and drawing activities, the same materials will be provided in each department and for each group, including small figurines, animals, shapes (such as cubes, triangles, circles), small plush toys, markers, colored pencils, and A4 white sheets of paper.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06443320